Global bully goes to Guatemala

This entry reprints a column by Russell Mokhiber and Robert Weissman from November 16, 2005, called "Global bully goes to Guatemala." It reports on the pressures being put on Guatemala by the US government, on behalf of large drug companies. The article correctly singles out Pfizer, which is the most important advocate of an aggressive US trade policy on matters concerning intellectual property protection on medicines in poor countries. The current dispute involving the Philippines should be seen in this wider context.